Nuvalent, Inc. (NUVL)

107.38 +2.43 (+2.32%) USD  |  NASDAQ  |  May 27, 16:00
107.46 +0.08 (+0.07%) After-Hours: 20:00
More

Nuvalent Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Cogent Biosciences, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
Vera Therapeutics, Inc. Upgrade
Tyra Biosciences, Inc. Upgrade